Linc-KILH potentiates Notch1 signaling through inhibiting KRT19 phosphorylation and promotes the malignancy of hepatocellular carcinoma

Zhang, Xudong; Xu, Xiaoliang; Zhang, Zechuan; Xue, Cailin; Kong, Zhijun; Wu, Siyuan; Yun, Xiao; Fu, Yue; Zhu, Chunfu; Qin, Xihu

doi:10.7150/ijbs.52279



Theranostics

International Journal of Medical Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Biol Sci 2021; 17(3):768-780. doi:10.7150/ijbs.52279 This issue Cite

Research Paper

Linc-KILH potentiates Notch1 signaling through inhibiting KRT19 phosphorylation and promotes the malignancy of hepatocellular carcinoma

Xudong Zhang^1#, Xiaoliang Xu^2,3#, Zechuan Zhang^3#, Cailin Xue¹, Zhijun Kong¹, Siyuan Wu¹, Xiao Yun¹, Yue Fu¹, Chunfu Zhu^1✉, Xihu Qin^1✉

1. The Affiliated Changzhou NO.2 People's Hospital of Nanjing Medical University, 29 XingLongXiang Road, Changzhou, Jiangsu 213000, P.R. China.
2. School of medicine, Southeast University, Nanjing, China.
3. Department of Hepatobiliary Surgery of Nanjing Drum Tower Hospital, Nanjing Medical University, Nanjing, China.
#These authors contributed equally to this work.

Citation:

Zhang X, Xu X, Zhang Z, Xue C, Kong Z, Wu S, Yun X, Fu Y, Zhu C, Qin X. Linc-KILH potentiates Notch1 signaling through inhibiting KRT19 phosphorylation and promotes the malignancy of hepatocellular carcinoma. Int J Biol Sci 2021; 17(3):768-780. doi:10.7150/ijbs.52279. https://www.ijbs.com/v17p0768.htm

Other styles

Abstract

Long noncoding RNAs (LncRNAs) are emerging as crucial regulators in the pathophysiological process of various tumors, including HCC. Here, we identify a novel lncRNA Linc-KILH (KRT19 interacting long noncoding RNA in hepatocellular carcinoma), which is significantly up-regulated in HCC tissues and positively correlated with larger tumor size, severer microvascular invasion, more intrahepatic metastasis and decreased survival of HCC patients. Silence of Linc-KILH remarkably inhibited the proliferation and metastasis abilities of KRT19-positive HCC cells in vitro and in vivo. Mechanistically, Linc-KILH interacts with KRT19 and then inhibits the phosphorylation of KRT19 on Ser35, thereby, enhancing the translocation of KRT19 from cytoplasm to membrane in KRT19 positive HCC cells. Additionally, we validated that KRT19 interacts with β-catenin but not RAC1 in HCC cells. Linc-KILH enhanced the interaction between β-catenin and KRT19 in cytoplasm and promoted the nuclear translocation of β-catenin in HCC cells. Furthermore, Linc-KILH could enhance the promoting function of KRT19 on Notch1 signaling with the existence of KRT19 in HCC cells. Collectively, we revealed that Linc-KILH exerts a vital function in KRT19 positive HCC progression and may likely be developed into an effective therapeutic target for HCC.

Keywords: hepatocellular carcinoma, microvascular invasion, long noncoding RNAs

Citation styles

APA

Zhang, X., Xu, X., Zhang, Z., Xue, C., Kong, Z., Wu, S., Yun, X., Fu, Y., Zhu, C., Qin, X. (2021). Linc-KILH potentiates Notch1 signaling through inhibiting KRT19 phosphorylation and promotes the malignancy of hepatocellular carcinoma. International Journal of Biological Sciences, 17(3), 768-780. https://doi.org/10.7150/ijbs.52279.

ACS

Zhang, X.; Xu, X.; Zhang, Z.; Xue, C.; Kong, Z.; Wu, S.; Yun, X.; Fu, Y.; Zhu, C.; Qin, X. Linc-KILH potentiates Notch1 signaling through inhibiting KRT19 phosphorylation and promotes the malignancy of hepatocellular carcinoma. Int. J. Biol. Sci. 2021, 17 (3), 768-780. DOI: 10.7150/ijbs.52279.

NLM

CSE

Zhang X, Xu X, Zhang Z, Xue C, Kong Z, Wu S, Yun X, Fu Y, Zhu C, Qin X. 2021. Linc-KILH potentiates Notch1 signaling through inhibiting KRT19 phosphorylation and promotes the malignancy of hepatocellular carcinoma. Int J Biol Sci. 17(3):768-780.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.